Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
“The Marie Skłodowska-Curie grant allowed me to come back to Barcelona and to clinical research”
Dr Marc Suárez-Calvet explains his experience and the current stage of the project that he has led with European funding
BBRC presented data from the ALFA study at CTAD
Alzforum reports on the presentations exposed by José Luis Molinuevo and other researchers at the 12th Clinical Trials on Alzheimer’s Disease conference
New study finds changes in brain structure and cognition in people with insomnia
The research opens the door to a new line of research that will analyze the relationship between sleep quality and Alzheimer’s risk
BBRC and IMIM kick off a clinical trial of dementia prevention on people with memory problems
The PENSA Study will combine a program of interventions in lifestyle habits and the ingestion of a preparation based on a component from the green tea
New study relates alterations in white and gray matters and cognition
The results complement previous findings with participants of the Alfa Study
A study by BBRC and Hospital Clínic finds brain changes in healthy people with subjective cognitive impairment
The results show that people with beta-amyloid alteration and subjective perception of cognitive impairment have cerebral volume loss in areas associated with Alzheimer’s disease
José Luis Molinuevo explains Alzheimer’s research advances in the Science Week
The Scientific Director of Alzheimer’s Prevention Program of the BBRC participated in BCNSpiracy, a scientific dissemination event held in CosmoCaixa
BBRC researchers participate in the General Assembly of the AMYPAD project
The meeting took place on October 10 and 11 in Barcelona
Dr. José Luis Molinuevo participates in a paper that recommends informing about beta amyloid as a risk factor for dementia
The vision, which is signed by scientists from international centers, has been published in Lancet Neurology
